Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2005

01-10-2005 | Review article

Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside

Authors: K. M. Chow, A. C. Hui, C. C. Szeto

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2005

Login to get access

Abstract

Central nervous system toxicity following administration of beta-lactam antibiotics, of which penicillin is the prototype, is a potential cause of morbidity and mortality. In recent years, important advances have been made in the pathogenesis of antibiotic-related neurotoxicity. This review focuses on the experimental and clinical aspects of neurotoxicity caused by beta-lactam antibiotics. The purpose is to provide an update on the pathogenesis, mechanism, and clinical manifestations of the neurotoxicity, along with an overview of the relationship between antibiotic structure and convulsive action. In particular, some of the prevailing ideas about pathogenesis are highlighted, including theories of the mechanism of pathogencity. A better understanding of antibiotic-related neurotoxicity, as derived from animal models and human clinical experience, would be of value in facilitating more efficient and safer use of antimicrobial compounds.
Literature
1.
go back to reference Walker AE, Johnson HC, Kollros JJ (1945) Penicillin convulsions: the convulsive effects of penicillin applied to the cerebral cortex of monkey and man. Surg Gynecol Obstet 81:692–701 Walker AE, Johnson HC, Kollros JJ (1945) Penicillin convulsions: the convulsive effects of penicillin applied to the cerebral cortex of monkey and man. Surg Gynecol Obstet 81:692–701
2.
go back to reference Johnson HC, Walker AE (1945) Intraventricular penicillin. JAMA 27:217–219 Johnson HC, Walker AE (1945) Intraventricular penicillin. JAMA 27:217–219
3.
go back to reference Walker AE, Johnson HC (1945) Convulsive factor in commercial penicillin. Arch Surg 50:69–73 Walker AE, Johnson HC (1945) Convulsive factor in commercial penicillin. Arch Surg 50:69–73
4.
go back to reference Niedermeyer E (1995) A. Earl Walker: neurosurgeon, neuroscientist, and epileptologist. Epilepsia 36:516–521CrossRefPubMed Niedermeyer E (1995) A. Earl Walker: neurosurgeon, neuroscientist, and epileptologist. Epilepsia 36:516–521CrossRefPubMed
5.
go back to reference Reuling S, Cramer C (1945) Intrathecal penicillin. JAMA 27:16–18 Reuling S, Cramer C (1945) Intrathecal penicillin. JAMA 27:16–18
6.
go back to reference Dumoff-Stanley E, Dawling H, Swett L (1946) The absorption into and distribution of penicillin in the cerebrospinal fluid. J Clin Invest 25:87–93PubMedCrossRef Dumoff-Stanley E, Dawling H, Swett L (1946) The absorption into and distribution of penicillin in the cerebrospinal fluid. J Clin Invest 25:87–93PubMedCrossRef
7.
go back to reference Smith H, Lerner PI, Weinstein L (1967) Neurotoxicity and “massive” intravenous therapy with penicillin: a study of possible predisposing factors. Arch Intern Med 120:47–53CrossRefPubMed Smith H, Lerner PI, Weinstein L (1967) Neurotoxicity and “massive” intravenous therapy with penicillin: a study of possible predisposing factors. Arch Intern Med 120:47–53CrossRefPubMed
8.
go back to reference Chow KM, Szeto CC, Hui AC, Wong TY, Li PK (2003) Retrospective review of neurotoxicity induced by cefepime and ceftazidime. Pharmacotherapy 23:369–373CrossRefPubMed Chow KM, Szeto CC, Hui AC, Wong TY, Li PK (2003) Retrospective review of neurotoxicity induced by cefepime and ceftazidime. Pharmacotherapy 23:369–373CrossRefPubMed
10.
go back to reference DeLorey TM, Olsen RW (1992) γ-aminobutyric acidA receptor structure and function. J Biol Chem 267:16747–16750PubMed DeLorey TM, Olsen RW (1992) γ-aminobutyric acidA receptor structure and function. J Biol Chem 267:16747–16750PubMed
12.
go back to reference Barrons RW, Murray KM, Richey RM (1992) Populations at risk for penicillin-induced seizures. Ann Pharmacother 26:26–29PubMed Barrons RW, Murray KM, Richey RM (1992) Populations at risk for penicillin-induced seizures. Ann Pharmacother 26:26–29PubMed
13.
go back to reference Antoniadis A, Müller WE, Wollert U (1980) Inhibition of GABA and benzodiazepine receptor binding by penicillins. Neurosci Lett 18:309–312CrossRefPubMed Antoniadis A, Müller WE, Wollert U (1980) Inhibition of GABA and benzodiazepine receptor binding by penicillins. Neurosci Lett 18:309–312CrossRefPubMed
14.
go back to reference Twyman RE, Green RM, MacDonald RL (1992) Kinetics of open channel block by penicillin of single GABAA receptor channels from mouse spinal cord neurons in culture. J Physiol 445:97–127PubMed Twyman RE, Green RM, MacDonald RL (1992) Kinetics of open channel block by penicillin of single GABAA receptor channels from mouse spinal cord neurons in culture. J Physiol 445:97–127PubMed
15.
go back to reference Fujimoto M, Munakata M, Akaike N (1995) Dual mechanisms of GABAA response inhibition by beta-lactam antibiotics in the pyramidal neurons of the cerebral cortex. Br J Pharmacol 116:3014–3020PubMed Fujimoto M, Munakata M, Akaike N (1995) Dual mechanisms of GABAA response inhibition by beta-lactam antibiotics in the pyramidal neurons of the cerebral cortex. Br J Pharmacol 116:3014–3020PubMed
16.
go back to reference Antoniadis A, Müller WE, Wollert U (1980) Benzodiazepine receptor interactions may be involved in the neurotoxicity of various penicillin derivatives. Ann Neurol 8:71–73CrossRefPubMed Antoniadis A, Müller WE, Wollert U (1980) Benzodiazepine receptor interactions may be involved in the neurotoxicity of various penicillin derivatives. Ann Neurol 8:71–73CrossRefPubMed
17.
go back to reference Sugimoto M, Fukami S, Kayakiri H, Yamazaki S, Matsuoka N, Uchida I, Mashimo T (2001) The β-lactam antibiotics, penicillin-G and cefoselis have different mechanisms and sites of action at GABAA receptors. Br J Pharmacol 135:427–432CrossRef Sugimoto M, Fukami S, Kayakiri H, Yamazaki S, Matsuoka N, Uchida I, Mashimo T (2001) The β-lactam antibiotics, penicillin-G and cefoselis have different mechanisms and sites of action at GABAA receptors. Br J Pharmacol 135:427–432CrossRef
18.
go back to reference Gurley D, Amin J, Ross PC, Weiss DS, White G (1995) Point mutations in the M2 region of the alpha, beta, or gamma subunit of the GABAA channel that abolish block by picrotoxin. Receptors Channels 3:13–20PubMed Gurley D, Amin J, Ross PC, Weiss DS, White G (1995) Point mutations in the M2 region of the alpha, beta, or gamma subunit of the GABAA channel that abolish block by picrotoxin. Receptors Channels 3:13–20PubMed
19.
go back to reference Lindquist CE, Dalziel JE, Cromer BA, Birnir B (2004) Penicillin blocks human α1β1 and α1β1γ2S GABAA channels that open spontaneously. Eur J Pharmacol 496:23–32CrossRefPubMed Lindquist CE, Dalziel JE, Cromer BA, Birnir B (2004) Penicillin blocks human α1β1 and α1β1γ2S GABAA channels that open spontaneously. Eur J Pharmacol 496:23–32CrossRefPubMed
20.
go back to reference Hori S, Kurioka S, Matsuda M, Shimada J (1985) Inhibitory effect of cephalosporins on γ-aminobutyric acid receptor binding in rat synaptic membranes. Antimicrob Agents Chemother 27:650–651PubMed Hori S, Kurioka S, Matsuda M, Shimada J (1985) Inhibitory effect of cephalosporins on γ-aminobutyric acid receptor binding in rat synaptic membranes. Antimicrob Agents Chemother 27:650–651PubMed
21.
go back to reference Sugimoto M, Uchida I, Mashimo T, Yamazaki S, Hatano K, Ikeda F, Mochizuki Y, Terai T, Matsuoka N (2003) Evidence for the involvement of GABAA receptor blockade in convulsions induced by cephalosporins. Neuropharmacology 45:304–314CrossRefPubMed Sugimoto M, Uchida I, Mashimo T, Yamazaki S, Hatano K, Ikeda F, Mochizuki Y, Terai T, Matsuoka N (2003) Evidence for the involvement of GABAA receptor blockade in convulsions induced by cephalosporins. Neuropharmacology 45:304–314CrossRefPubMed
22.
go back to reference Grøndahl TØ, Langmoen IA (1993) Epileptogenic effect of antibiotic drugs. J Neurosurg 78:938–943 Grøndahl TØ, Langmoen IA (1993) Epileptogenic effect of antibiotic drugs. J Neurosurg 78:938–943
23.
go back to reference Gutnick MJ, Prince DA (1971) Penicillinase and the convulsant action of penicillin. Neurology 21:759–764PubMed Gutnick MJ, Prince DA (1971) Penicillinase and the convulsant action of penicillin. Neurology 21:759–764PubMed
24.
go back to reference Esplin B, Théorêt E, Seward E, Capek R (1985) Epileptogenic action of penicillin derivatives: structure–activity relationship. Neuropharmacology 24:571–575CrossRefPubMed Esplin B, Théorêt E, Seward E, Capek R (1985) Epileptogenic action of penicillin derivatives: structure–activity relationship. Neuropharmacology 24:571–575CrossRefPubMed
25.
go back to reference Kamei C, Sunami A, Tasaka K (1983) Epileptogenic activity of cephalosporins in rats and their structure–activity relationship. Epilepsia 24:431–439PubMedCrossRef Kamei C, Sunami A, Tasaka K (1983) Epileptogenic activity of cephalosporins in rats and their structure–activity relationship. Epilepsia 24:431–439PubMedCrossRef
26.
go back to reference De Sarro A, De Sarro GB, Ascioti C, Nistico G (1989) Epileptogenic activity of some beta-lactam derivatives: structure–activity relationship. Neuropharmacology 28:359–365CrossRefPubMed De Sarro A, De Sarro GB, Ascioti C, Nistico G (1989) Epileptogenic activity of some beta-lactam derivatives: structure–activity relationship. Neuropharmacology 28:359–365CrossRefPubMed
27.
go back to reference Hantson P, Léonard F, Maloteaux JM, Mahieu P (1999) How epileptogenic are the recent antibiotics? Acta Clin Belg 54:80–87PubMed Hantson P, Léonard F, Maloteaux JM, Mahieu P (1999) How epileptogenic are the recent antibiotics? Acta Clin Belg 54:80–87PubMed
28.
go back to reference Williams PD, Bennett DB, Comereski CR (1988) Animal model for evaluating the convulsive liability of β-lactam antibiotics. Antimicrob Agents Chemother 32:758–760PubMed Williams PD, Bennett DB, Comereski CR (1988) Animal model for evaluating the convulsive liability of β-lactam antibiotics. Antimicrob Agents Chemother 32:758–760PubMed
29.
go back to reference Schliamser SE, Cars O, Norrby SR (1991) Neurotoxicity of β-lactam antibiotics: predisposing factors and pathogenesis. J Antimicrob Chemother 27:405–425PubMedCrossRef Schliamser SE, Cars O, Norrby SR (1991) Neurotoxicity of β-lactam antibiotics: predisposing factors and pathogenesis. J Antimicrob Chemother 27:405–425PubMedCrossRef
30.
go back to reference Chatellier D, Jourdain M, Mangalaboyi J, Ader F, Chopin C, Derambure P, Fourrier F (2002) Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure. Intensive Care Med 28:214–217CrossRefPubMed Chatellier D, Jourdain M, Mangalaboyi J, Ader F, Chopin C, Derambure P, Fourrier F (2002) Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure. Intensive Care Med 28:214–217CrossRefPubMed
31.
go back to reference Chow KM, Szeto CC, Hui AC, Li PK (2004) Mechanisms of antibiotic neurotoxicity in renal failure. Int J Antimicrob Agents 23:213–217CrossRefPubMed Chow KM, Szeto CC, Hui AC, Li PK (2004) Mechanisms of antibiotic neurotoxicity in renal failure. Int J Antimicrob Agents 23:213–217CrossRefPubMed
32.
go back to reference Hantson P, Leonard F, Maloteaux JM, Mahieu P (1999) How epileptogenic are the recent antibiotics? Acta Clin Belg 54:80–87PubMed Hantson P, Leonard F, Maloteaux JM, Mahieu P (1999) How epileptogenic are the recent antibiotics? Acta Clin Belg 54:80–87PubMed
33.
go back to reference Norrby SR (2000) Neurotoxicity of carbapenem antibiotics: consequences for their use in bacterial meningitis. J Antimicrob Chemother 45:5–7CrossRefPubMed Norrby SR (2000) Neurotoxicity of carbapenem antibiotics: consequences for their use in bacterial meningitis. J Antimicrob Chemother 45:5–7CrossRefPubMed
34.
go back to reference Seamans KB, Gloor P, Dobell RA, Wyant JD (1968) Penicillin-induced seizures during cardiopulmonary bypass: a clinical and electroencephalographic study. N Engl J Med 278:861–868PubMedCrossRef Seamans KB, Gloor P, Dobell RA, Wyant JD (1968) Penicillin-induced seizures during cardiopulmonary bypass: a clinical and electroencephalographic study. N Engl J Med 278:861–868PubMedCrossRef
35.
go back to reference Snavely SR, Hodges GR (1984) The neurotoxicity of antibacterial agents. Ann Intern Med 101:92–104PubMed Snavely SR, Hodges GR (1984) The neurotoxicity of antibacterial agents. Ann Intern Med 101:92–104PubMed
36.
go back to reference Martínez-Rodríguez JE, Barriga FJ, Santamaria J, Iranzo A, Pareja JA, Revilla M, dela Rosa CR (2001) Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure. Am J Med 111:115–119CrossRefPubMed Martínez-Rodríguez JE, Barriga FJ, Santamaria J, Iranzo A, Pareja JA, Revilla M, dela Rosa CR (2001) Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure. Am J Med 111:115–119CrossRefPubMed
37.
go back to reference Chow KM, Wang AY, Hui CF, Wong TY, Szeto CC, Li PK (2001) Nonconvulsive status epilepticus in peritoneal dialysis. Am J Kidney Dis 38:400–405PubMed Chow KM, Wang AY, Hui CF, Wong TY, Szeto CC, Li PK (2001) Nonconvulsive status epilepticus in peritoneal dialysis. Am J Kidney Dis 38:400–405PubMed
38.
go back to reference Bechtel TP, Slaughter RL, Moore TD (1980) Seizures associated with high cerebrospinal fluid concentrations of cefazolin. Am J Hosp Pharm 37:271–273PubMed Bechtel TP, Slaughter RL, Moore TD (1980) Seizures associated with high cerebrospinal fluid concentrations of cefazolin. Am J Hosp Pharm 37:271–273PubMed
39.
go back to reference Nagata M, Yasuhara M (2001) Effect of experimental renal failure on the pharmacodynamics of cefoselis-induced seizures in rats. Biol Pharm Bull 24:1049–1052CrossRefPubMed Nagata M, Yasuhara M (2001) Effect of experimental renal failure on the pharmacodynamics of cefoselis-induced seizures in rats. Biol Pharm Bull 24:1049–1052CrossRefPubMed
40.
go back to reference Schliamser SE, Bolander H, Kourtopoulos H, Norrby SR (1988) Neurotoxicity of benzylpenicillin: correlation to concentrations in serum, cerebrospinal fluid and brain tissue fluid in rabbits. J Antimicrob Chemother 21:365–372PubMedCrossRef Schliamser SE, Bolander H, Kourtopoulos H, Norrby SR (1988) Neurotoxicity of benzylpenicillin: correlation to concentrations in serum, cerebrospinal fluid and brain tissue fluid in rabbits. J Antimicrob Chemother 21:365–372PubMedCrossRef
41.
go back to reference Schliamser SE, Bolander H, Broholm KA, Gerdes U, Kourtopoulos H, Norrby SR (1989) Neurotoxicity of benzylpenicillin in experimental renal failure and Enterobacter cloacae meningitis. J Antimicrob Chemother 24:215–225PubMedCrossRef Schliamser SE, Bolander H, Broholm KA, Gerdes U, Kourtopoulos H, Norrby SR (1989) Neurotoxicity of benzylpenicillin in experimental renal failure and Enterobacter cloacae meningitis. J Antimicrob Chemother 24:215–225PubMedCrossRef
42.
go back to reference Brouns R, De Deyn PP (2004) Neurological complications in renal failure: a review. Clin Neurol Neurosurg 107:1–16CrossRefPubMed Brouns R, De Deyn PP (2004) Neurological complications in renal failure: a review. Clin Neurol Neurosurg 107:1–16CrossRefPubMed
43.
go back to reference Calandra G, Lydick E, Carrigan J, Weiss L, Guess H (1988) Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin. Am J Med 84:911–918CrossRefPubMed Calandra G, Lydick E, Carrigan J, Weiss L, Guess H (1988) Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin. Am J Med 84:911–918CrossRefPubMed
Metadata
Title
Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside
Authors
K. M. Chow
A. C. Hui
C. C. Szeto
Publication date
01-10-2005
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2005
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-005-0021-y

Other articles of this Issue 10/2005

European Journal of Clinical Microbiology & Infectious Diseases 10/2005 Go to the issue

Announcements

Announcements

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.